No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investor Portal
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Biotech
Vincere lands grant funding for research into mitophagy enhancing Parkinson’s drug
Biotech
Genflow makes progress towards clinical trial of NASH gene therapy
Biotech
Standing at the precipice of a biotech renaissance – the confluence of AI and SynBio
The coming together of two of the most transformative technologies of our age will shine a light on our manipulation of biological systems.
Biotech
The quest for rejuvenation without reprogramming
Biotech
Nine Square Therapeutics lands $4.5m to advance development of novel Parkin activators
Biotech
Rejuveron lands $75m to advance healthy aging portfolio; expands focus in Middle East
Biotech
Alnylam drug shown to reduce blood pressure in Phase 2 trial
Biotech
Telomere-boosting mRNA therapeutic turns back the aging clock
Biotech
Rejuvenation Technologies exits stealth with $10.6m for age-reversing mRNA therapeutics
Biotech
Hyperbaric oxygen therapy – a patient’s perspective
Biotech
Young blood rising: new plasma therapy moves closer to the clinic
Biotech
Clock.bio launches to decode rejuvenation biology across human genome
Biotech
AgeX to merge with Serina Therapeutics
Biotech
BlueRock’s cell therapy shows early promise in Parkinson’s study
Biotech
Do long-lived flies hold the key to extending human longevity?
Biotech
Neuronascent lands NIA grant to advance Alzheimer’s treatment to Phase 2 clinical trials
Biotech
Mitrix presents mitochondrial bioreactor technology at Longevity Summit Dublin
Biotech
Vaxxinity publishes positive results in Alzheimer’s trial
Biotech
Powering precision medicine with proteomics
Biotech
Novel approach can engineer blood vessels
Biotech
Rejuvenate Biomed publishes promising sarcopenia data for metformin and galantamine combination
Biotech
Finding the recipe for success in cell therapy
Biotech
MyMD reports positive results in Phase 2 sarcopenia trial
Biotech
Protein-targeting vaccine signposts Alzheimer’s breakthrough
Biotech
FOXO Technologies launches bioinformatics services and hopes to revolutionize epigenetic data analysis
Biotech
Focal Biosciences: new cellular reprogramming startup unveiled
Biotech
Biophytis applies to commence “first ever” Phase 3 sarcopenia trial
Biotech
Skyline gets green light for AMD gene therapy trial
Biotech
Insilico doses first patients in Phase 2 IPF trial
Biotech
Cognition Therapeutics reports positive Alzheimer’s clinical trial results
Biotech
Celmatix identifies leads in oral fertility drug program
Biotech
Verge reports positive clinical trial results for AI-discovered ALS drug
Biotech
Load More